Edouard P, Thivolet C, Bedossa P, Olivi M, Legrand B, Bendelac A, Bach J F, Carnaud C
INSERM U25, Hôpital Necker, Paris, France.
Eur J Immunol. 1993 Mar;23(3):727-33. doi: 10.1002/eji.1830230324.
Non-obese diabetic (NOD) mice become spontaneously diabetic as a result of a genetically programmed autoimmune process mediated by autoreactive T lymphocytes and directed against beta cell antigen(s). Studies dealing with T cell receptor (TcR) variable (V) gene usage by such autoreactive T lymphocytes have given contrasted results. Various reasons may explain these discrepancies: the multiplicity of antigenic epitopes putatively recognized by T cells, the ambiguity between specifically committed T cells and passenger lymphocytes homing randomly to the pancreas, the necessarily limited size of the T cell clone panels which have been analyzed for TcR rearrangements and, last but not least, the flexibility of T cell repertoires. To circumvent some of these difficulties, we have decided to concentrate upon the T cell population present in diseased animals and capable of transferring diabetes into young naive NOD recipients. This population, composed of CD4+ and CD8+ T cells, is presumably committed against the relevant beta cell antigens and is the most likely to reveal a bias in V gene usage if such a bias does indeed exist. To find out whether certain V beta genes are more frequently used than others by such pathogenic T cells, T lymphocytes from diabetic donors have been depleted in vitro of defined V beta subsets before being reinoculated into permissive recipients. Out of four V beta families probed under such conditions, three (V beta 8, V beta 5 and V beta 11) are neutral. Their absence neither increases nor reduces the final incidence of successful transfers, indicating that these gene segments are not preferentially used. In contrast, the depletion of V beta 6-positive T cells results in a severe reduction of transfers, suggesting that V beta 6 gene is used with a relatively high frequency by diabetogenic CD4+ and/or CD8+ T cells. To define more precisely which subset uses V beta 6 gene preferentially, we have performed mixing experiments with deleted and intact subsets. The results, based on disease transfer and insulitis severity, indicate that the V beta 6 bias affects predominantly the CD4+ subset. Thus, at variance with several studies concluding that V gene usage in NOD mice is heterogeneous, our present data suggest that disease transferring T cells use a relatively restricted set of V beta genes.
非肥胖糖尿病(NOD)小鼠由于自身反应性T淋巴细胞介导的基因程序性自身免疫过程,且该过程针对β细胞抗原,从而自发患糖尿病。关于此类自身反应性T淋巴细胞T细胞受体(TcR)可变(V)基因使用情况的研究得出了相互矛盾的结果。多种原因可解释这些差异:T细胞可能识别的抗原表位的多样性、特异性定向T细胞与随机归巢至胰腺的过客淋巴细胞之间的模糊性、为分析TcR重排而分析的T细胞克隆库规模必然有限,以及T细胞库的灵活性。为规避其中一些困难,我们决定专注于患病动物体内存在的、能够将糖尿病转移至年轻的未致敏NOD受体的T细胞群体。该群体由CD4⁺和CD8⁺T细胞组成,推测针对相关β细胞抗原,并且如果确实存在V基因使用偏好,那么该群体最有可能揭示这种偏好。为了弄清楚此类致病性T细胞是否比其他细胞更频繁地使用某些Vβ基因,来自糖尿病供体的T淋巴细胞在体外被去除特定的Vβ亚群,然后再接种到易感受体中。在这种条件下检测的四个Vβ家族中,有三个(Vβ8、Vβ5和Vβ11)是中性的。它们的缺失既不增加也不降低成功转移的最终发生率,这表明这些基因片段未被优先使用。相比之下,去除Vβ6阳性T细胞会导致转移严重减少,这表明致糖尿病的CD4⁺和/或CD8⁺T细胞相对频繁地使用Vβ6基因。为了更精确地确定哪个亚群优先使用Vβ6基因,我们用缺失和完整的亚群进行了混合实验。基于疾病转移和胰岛炎严重程度的结果表明,Vβ6偏好主要影响CD4⁺亚群。因此,与一些得出NOD小鼠V基因使用情况异质性结论的研究不同,我们目前的数据表明,疾病转移T细胞使用相对有限的一组Vβ基因。